|
Volumn 16, Issue 6, 2010, Pages 1016-1019
|
American Association of Clinical Endocrinologists medical guildlines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis: Executive summary of recommendations
a a a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
25 HYDROXYVITAMIN D;
ALENDRONIC ACID;
CALCITONIN;
CALCIUM;
DENOSUMAB;
IBANDRONIC ACID;
PARATHYROID HORMONE[1-34];
RALOXIFENE;
RISEDRONIC ACID;
VITAMIN D;
ZOLEDRONIC ACID;
BONE DENSITY;
BONE TURNOVER;
CALCIUM INTAKE;
CLINICAL PRACTICE;
DIET SUPPLEMENTATION;
DUAL ENERGY X RAY ABSORPTIOMETRY;
FRAGILITY FRACTURE;
HEALTH CARE PERSONNEL;
HUMAN;
LIFESTYLE;
MEDICAL DECISION MAKING;
MEDICAL LITERATURE;
MEDICAL SOCIETY;
OCCUPATIONAL THERAPY;
OSTEOLYSIS;
PATIENT MONITORING;
PATIENT REFERRAL;
PHYSIOTHERAPY;
POSTMENOPAUSE OSTEOPOROSIS;
PRACTICE GUIDELINE;
PROTEIN INTAKE;
RISK FACTOR;
SECONDARY OSTEOPOROSIS;
SHORT SURVEY;
VERTEBRA FRACTURE;
VITAMIN BLOOD LEVEL;
VITAMIN INTAKE;
VITAMIN SUPPLEMENTATION;
WEIGHT BEARING;
|
EID: 79952394479
PISSN: 1530891X
EISSN: None
Source Type: Journal
DOI: 10.4158/EP.16.6.1016 Document Type: Short Survey |
Times cited : (212)
|
References (0)
|